Cameco Corporation (CCO.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Cameco Corporation (CCO.TO)

141.60

+0.41 (0.29%)

as of Aug 24, 2026, 8:00:00 pm Market Open.

547 watching

Investor Insights

Aug 24, 2026, 12:00 am

This summary was created by AI, based on 38 opinions in the last 12 months.

Cameco Corporation (CCO-T) is viewed positively among analysts, primarily due to its pivotal role in the uranium sector amid a growing demand for clean energy and nuclear power. Experts underscore its increasing significance with the rising reliance on nuclear energy, particularly for data center power supplies, as well as company initiatives such as its 50% stake in Westinghouse. While its long-term prospects remain optimistic owing to robust demand, there are concerns regarding its current valuation, which is seen as high by several analysts despite strong growth potential and attractive future earnings. Short-term volatility, driven by profit-taking and market fluctuations, adds a layer of caution for potential investors, pointing towards strategic buying opportunities on pullbacks. Overall, the sentiment is that CCO is well-positioned for future growth, provided investors can navigate through necessary corrections and volatility in the uranium market.

Consensus

Positive

Valuation

Overvalued

Similar

Uranium, URA

BUY

CCO vs. NXE He'd prefer CCO, as it's more mature. Outlook for uranium is quite positive, given war in Ukraine and energy bottlenecks. High quality. Well run, efficient. Pays a dividend.

BUY

CCO vs. NXE Uranium looks good, one of the sectors that's up on the year. Demand is strong, supply is getting tighter. Institutional quality, anyone can invest in it. Good cycle in front of us. Whereas NXE is a much-earlier-stage company, so risks are higher. He owns both.

WEAK BUY

CCO vs. NXE He'd lean towards CCO, go-to name, largest producer in the world. The large players attract more international interest. NXE is a small cap, it may not get as much interest, and so the valuation may not get as high. CCO valuation is a bit extended. Outlook for uranium is positive. He'd look at the Sprott U.UN, which is a direct play on uranium prices, rather than the producers.

BUY

Shown good discipline managing supply into the market. Good proxy for uranium, which looks good going forward. Future will be more modular, smaller scale and capex. Yield around only 0.5%, which he could see growing over time.

BUY

Allan Tong’s Discover Picks Despite these realities, nuclear is coming back and so is uranium, its essential ingredient. Cameco is the go-to stock here. U.S. President Biden announced in early June that he’s pushing for $4.3 billion plan to buy enriched uranium from domestic producers to wean the country off Vladimir Putin’s supply. On June 7, shares of Cameco soared from roughly $31.40 to $34.40. Shares peeled back over the rest of the week, but remained well above $32.50. Even prior to that, Cameco was making 52-week highs, touching $40 in mid-April, nearly double its late-January price. Cameco has momentum. Read 3 rock stars of the mineral stocks for our full analysis.

HOLD

Lots of volatility in the space, but sees the 2-5 year trend going up. Uranium price has to clear 75 USD to incentivize production necessary for the world to continue to increase its standard of living in carbon-free electrical generation. Second-best in the world. Nice free cash. Reasonable dividend.

BUY ON WEAKNESS

uranium stocks outlook Nuclear power is one of the few ways of solving the need for non-fossil fuel energy, but these plants need 10-15 years to build. Plants in China and the Middle East are in progress. Buy this below $30 and hold 10 years. It moves over a long period of time. He targets $50-60 in 3-5 years. Could be volatile short term.

PAST TOP PICK

(A Top Pick Feb 08/21, Up 42%) Uranium facing a supply shortage, which creates a large opportunity. Shift back to nuclear power is raising demand. Has recently sold position as stock price was too high. If share price falls to ~$20, will buy again.

Wealthica Track your Stocks in your Watch List

SELL

Overshot on valuation. Sold recently. Uranium price went up, but the next move needs demand in the market to move the price higher. Commodity prices will stall for the time being. If the valuation and commodity price were favourable, he'd revisit.

PAST TOP PICK

(A Top Pick Dec 15/20, Up 61%) Stock got way ahead of the commodity price, and the commodity price might stall out. It could be really volatile. Hopefully, the supply and demand will line up at a point in the future.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock moved up 10% on good revenues and earnings. The latest quarter beat estimates. Dividends were increased by 50%. EPS beat significantly. Can buy it today. Unlock Premium - Try 5i Free

BUY ON WEAKNESS

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock is down roughly 30% since highs. However, no real news has been reported. It broke their 200-day moving average, that could have brought out more sellers. Comfortable buying here. Unlock Premium - Try 5i Free

COMMENT

A uranium producer. Shares have done quite well. Nuclear is a viable, non-carbon energy producer, but can nuclear overcome negative impacts when things go terribly wrong (a nuclear accident). She doesn't know. To buy Cameco, you must have a positive, long-term outlook for uranium.

COMMENT

The biggest problem with nuclear power is no one wants it in their back yard. Germany, Japan and others are backing out of expansion, despite the benefit from a climate change perspective

WATCH

It's very hard to make nuclear investment which lasts 50-100 years when government policy can change in 5-10. He feels nuclear will be a growing part of power demand, because there's not enough green energy to offset carbon power. CCO is up on uranium prices climbing. Watch, but don't buy this. It pays only a modest dividend, and shares have doubled this year. Watch.

Showing 151 to 165 of 1,109 entries

Most Recent Experts

Rick Rule

Rule Investment Media

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Cameco Corporation (CCO.TO)